Navigation Links
DOs and DON’Ts of Study Start-Up: Best Practices to Improve Efficiency and Meet/Exceed Timelines, New Life Science Webinar Hosted by Xtalks

Toronto, Canada (PRWEB) July 11, 2013

Efficient and effective study start-up is crucial to the success of every study. From country and site selection to resource oversight, there are challenges embedded in every investigation that can impact study start and timely delivery.

In order to address these challenges and set the path for success, several questions should be considered:

  •     How do you select countries and sites that will improve your chances of finding and retaining the right patients for your study?
  •     Can you cost-effectively implement a proactive patient strategy, and avoid the need for rescue programs?
  •     How can you leverage data and planning techniques to minimize management oversight while optimizing efficiencies by matching studies, sites, and patients impacting patient health?

In this webinar, experts from Quintiles will discuss best practices for applying quantitative and qualitative information to develop study strategies, from feasibility through patient recruitment. The speakers will highlight how an empowered delivery team can enhance efficiency, minimize the need for extensive oversight, and deliver greater overall accountability for meeting your study goals.

Through case examples, we will show how the appropriate tools and insight from data and strategies are applied in a real-world setting to deliver tangible benefits to clinical development stakeholders.

To learn more about the event, visit:

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year, thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

Karen Lim (416) 977-6555 ext 227

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study Scavenger and Announce Alliance Utilizing Smart Phone Capabilities to Bring Clinical Trials to Motivated Subjects
2. New Approaches in Immunogenicity Assessment Using the New SQiDlite™ System: Case Study Analysis, New Life Science Webinar Hosted by Xtalks
3. New Study Reveals that PEEK Polymer Spinal Cage Is Superior to Titanium in Surgical Treatment of Multilevel Cervical Spondylotic Myelopathy
4. Americord Applauds Study on Stem Cell Therapy for Congenital Heart Defects
5. Study Data Tabulation Model in Real Time, New Webinar Hosted by Xtalks
6. RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants
7. Lilly and Incyte Announce Baricitinib Efficacy and Safety Data from the Open-Label, Long-Term Extension of the Phase 2b JADA Study in Patients with Rheumatoid Arthritis
8. Are Root Canals Headed for Obscurity? Stem Cell Study Indicates Maybe So
9. Adult Acne Treatment Explains a New Upcoming Study that may Change the Acne Treatment Industry
10. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
11. Endpoint Based Protocol Development: A Central Laboratory Perspective + Microbiology Case Study, New Life Science Webinar Hosted by Xtalks
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):